About Samuel Bjork
Samuel Bjork is an executive chair at Bonum Therapeutics.
Samuel Bjork first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Samuel Bjork in the role, so the role may have started earlier or lasted longer.
Bonum Therapeutics, Inc.
Executive Chair
2022 – 2026 · Seattle, WA
Develops targeted protein medicines for people with cancer.
Key Colleagues at Startups
The people Samuel Bjork works with at each company, as listed on that company's latest Form D.
Bonum Therapeutics, Inc. · Form D, Apr 17, 2026
Monique Schiersing
Senior Investment Director, Roche Venture
Neela Patel
Chief Business Officer
JM
John McKearn
Director
Diane Hollenbaugh
Chief Scientific Officer
Samuel Blackman
Independent Director
John Mulligan
Chief Executive Officer and director
Karl Handelsman
Founder & Managing Partner, Codon Capital, director
NW
Nicholas Walrod
Director
MM
Mitchell Mutz
Independent Director
Gaurav Aggarwal
Managing Partner, Vivo Capital and director